MS vs SERA · P/E 20, $344.27B cap vs rev $77.0K
Morgan Stanley (MS) versus Sera Prognostics Inc (SERA) — a side-by-side from cached financials, not a winner call.
Morgan Stanley (MS) is a capital markets company listed on US. It is led by Ted Pick.
Sera Prognostics Inc (SERA) is a medical devices company listed on US.
MS does not have a complete income-statement cache yet.
Latest reported SERA revenue for 2024-12-31 was $77.0K. Net income was -$32.9M. Revenue was down 74.8% from 2023-12-31 to 2024-12-31. SERA currently screens at market cap $89.1M.
MS currently screens at market cap $344.27B and trailing P/E 19.8. SERA currently screens at market cap $89.1M.
Not investment advice. Open the MS and SERA stock pages for the full models.
Not investment advice.